UK and Partners Receive Groundbreaking Grant

An elite $4 million NIH Research Evaluation and Commercialization Hub (REACH) grant received by the University of Kentucky, University of Louisville, Commonwealth Commercialization Center (C3) and the Kentucky Cabinet for Economic Development demonstrates the power of partnership while paving the way to bring dozens of new med-tech and health-related companies to life across the state in the coming years.

LEARN MORE
UK Campus

2018 Annual Report

2018 OTC Annual Report (click to open in Issuu)

The 2018 Annual Report shows how the OTC has been "Fostering Growth in Innovation" over the past year.

We want to thank the University of Kentucky research community for proving us right: there is an amazing amount of innovation going on at UK! 

This year was a period of growth for our office and UK commercialization capabilities. It was our first full year with a Commercialization & Licensing team, rolling out new marketing materials, licensing strategies and technology partnership initiatives. This growth led to 29 licenses and options executed in FY18, a 123% increase from last year and the most ever in a year for the University.

Read it now on Issuu  

 

By The Numbers

101 inventions

disclosed in FY 2018

$2.35 million

in gross royalty income in FY 2018

23 patents

issued to UK in FY 2018

$5 million

in income distributed to inventors since 2010

126 licenses & options

active as of June 30, 2018

$14.62 million

income distributed to colleges & departments since 2010

NIGMS Grant Update

Site Leads Group Photo

UK OTC, Partners Receive Phase II Funding for Southeast XLerator Network 

In October 2018, it was announced that the University of Kentucky (UK) , as the academic lead partner with XLerateHealth , a health technology accelerator based in Louisville, and regional partners had received a federal National Institutes of Health (NIH) grant that could potentially total $3.5 million over three years to create a hub to accelerate the commercialization of biomedical technologies. This hub, one of four NIGMS IDeA Hubs, will benefit university innovators and their commercialization resource partners in the Southeast Institutional Development Award (IDeA) region (AR, KY, LA, MS, PR, SC, and WV).

After Phase I planning, OTC is pleased to announce that funding for Phase II was awarded. The award provides $1.49 million to execute on the Phase I planning. In addition, the Southeast XLerator Network was awarded an Administrative Supplement of $250,000 to fund the advancement of promising health technologies with commercial potential across the region, which the Hub has called the “Ideas to Products (I2P)” program.